About this trial
This research is focused on evaluating pathways for identifying, managing, and overcoming side effects of cancer therapies that can negatively impact quality-of-life and overall outcomes for women during and after cancer treatment.
Questionnaire data to assess health related QoL (quality of life) and physical activity will be collected at baseline and at 6-monthly intervals at 3, 6 and 12 months throughout the study period. HR-QoL scores will be recorded at baseline to 6, 12, 18 and 24 months. Patients will be monitored by taking biobank bloods, bloods, ECG and cardiac echo as per the European Society of Cardiology Guidelines.
The study is being conducted in Galway University Hospital; Galway Clinic; Mayo University Hospital; Sligo General Hospital.
Patient Profile
Adult female patients (18 years and older) diagnosed with stage I-III breast cancer.
Where’s this trial being run?
Sligo University Hospital and University Hospital Galway
Can I join this study / trial?
The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.
Why not Print this page and bring it with you. It will help your doctor and research team advise you.
Print this pageFor more detailed information
Click HereQuestions?
Here’s a list of questions you may have for your doctor or local cancer research team.
QuestionsSummary Data
| Name: | UCARE |
|---|---|
| Number: | 24-21 |
| Full Title: | Understanding CARdiac Events in Breast Cancer – Pilot Cardio-Oncology Assessment and Surveillance Pathway for Breast Cancer Patients |
| Principal Investigator: | Professor Osama Soliman |
|---|---|
| Type: | Collaborative |
| Sponsor: | National University of Ireland, Galway |
| Recruitment Started: |
Global: n/a Ireland: January 2023 |
| Global Recruitment Target: | n/a |
|---|---|
| Ireland Recruitment Target: | 100 |